Genetic characterization of Sézary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situ hybridization

Haematologica

Volumn 89, Issue 2, 2004, Pages 165-173

  Espinet, Blanca ^a,d,h   Salido, Marta ^a   Pujol, Ramon M ^b   Florensa, Lourdes ^c   Gallardo, Fernando ^b   Domingo, Alícia ^b   Servitje, Octavio ^e   Estrach, Teresa ^f   García Muret, Pilar ^g   Woessner, Soledad ^d   Serrano, Sergi ^a,c   Solé, Francesc ^d  

^a Departament de Patologia   (Spain)

^b Servei de Dermatologia ^*  (Spain)

^c Servei de Patologia   (Spain)

^d Hospital Universitari del Mar   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h HOSPITAL DEL MAR   (Spain)

Author keywords

Cutaneous T cell lymphoma; Cytogenetics; RxFISH; S zary's syndrome

Indexed keywords

ALPHA INTERFERON; BLEOMYCIN; CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; FLUDARABINE; METHOTREXATE; PHYTOHEMAGGLUTININ; PREDNISONE; PSORALEN; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHROMOSOME 10; CHROMOSOME 18; CHROMOSOME 1Q; CHROMOSOME 2Q; CHROMOSOME 6Q; CHROMOSOME 8Q; CHROMOSOME 9; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CROSS SPECIES COLOR BANDING FLUORESCENT IN SITU HYBRIDIZATION; CYTOGENETICS; DIAGNOSTIC VALUE; DIPLOIDY; ERYTHRODERMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HUMAN; KARYOTYPE; KARYOTYPING; LYMPHADENOPATHY; MALE; PERIPHERAL CIRCULATION; PRURITUS; SEZARY SYNDROME; STATISTICAL ANALYSIS; T LYMPHOCYTE; TRISOMY 18; ANEUPLOIDY; ANIMAL; CELL TRANSFORMATION; CHROMOSOME BANDING PATTERN; CHROMOSOME BREAKAGE; COMPARATIVE STUDY; DNA PROBE; GENETICS; HAPLORHINI; MIDDLE AGED; MONOSOMY; SPAIN; SPECIES DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME BANDING; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 10; DNA PROBES; FEMALE; HUMANS; HYLOBATES; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MIDDLE AGED; MONOSOMY; SEZARY SYNDROME; SPAIN; SPECIES SPECIFICITY;

EID: 2942521753     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, et al. EORTC classification for cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-71.
2. Jaffe ES, Harris NL, Stein H, Vardiman JW, Editors. World Health Organization classification of tumours. Tumours of hematopoietic and lymphoid tissues. IARC Press, Lyon, 2001.
3. Fink-Puches R, Zenahlik P, Bäck B, Smolle J, Kerl H, Cerroni L. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a Large group of patients. Blood 2002;99:800-5.
4. Russell-Jones R, Whittaker S. Sézary syndrome: diagnostic criteria and therapeutic options. Semin Cutan Med Surg 2000;19:100-8.
5. Nowell PC, Finan JB, Vonderheid EC. Clonal characteristics of cutaneous T cell lymphomas: cytogenetic evidence from blood, lymph nodes and skin. J Invest Dermatol 1982;78:69-75.
6. Whang-Peng J, Bunn PA Jr, Knutsen T, Matthews MJ, Schechter G, Minna JD. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer 1982;50:1539-53.
7. Nowell PC, Vonderheid EC, Besa E, Hoxie JA, Moreau L, Finan JB. The most common chromosome change in 86 chronic B cell or T cell tumors: a 14q32 translocation. Cancer Genet Cytogenet 1986;19:219-27.
8. Berger R, Baranger L, Bernheim A, Valensi F, Flandrin G, Berheimm A. Cytogenetics of T-cell malignant lymphoma. Report of 17 cases and review of the chromosomal breakpoints. Cancer Genet Cytogenet 1988;36:123-30.
9. Sole F, Tarrida N, Coll MD, Caballin MR, De Miguel A, Woessner S, et al. Cytogenetic study of a patient with the Sézary syndrome. Cancer Genet Cytogenet 1990;44:193-6.
10. Sole F, Woessner S, Vallespi T, Perez Losada A, Florensa L, Irriguible D, et al. Cytogenetic studies in five patients with Sézary syndrome. Cancer Genet Cytogenet 1994;75:130-2.
11. Schlegelberger B, Himmler A, Bartles H, Kuse R, Sterry W, Grote W. Recurrent chromosome abnormalities in cutaneous T-cell lymphoma. Cancer Genet Cytogenet 1994;78:15-22.
12. Limon J, Nedoszytko B, Brozek I, Hellmann A, Zajaczek S, Lubinski J, et al. Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocytes on five cases with Sézary syndrome. Cancer Genet Cytogenet 1995;83:75-81.
13. Karenko L, Hyytinen E, Sarna S, Ranki A. Chromosomal abnormalities in cutaneous T-cell lymphoma and in its premalignant conditions as detected by G-banding and interphase cytogenetic methods. J Invest Dermatol 1997;108:22-9.
14. Thangavelu M, Finn WG, Yelavarthi KK, Roenigk HH Jr, Samuelson E, Peterson L, et al. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. Blood 1997;89:3371-7.
15. Wienberg J, Jauch A, Stanyon R, Cremer T. Molecular cytotaxonomy of primates by chromosomal in situ suppression hybridization. Genomics 1990;8:347-50.
16. Wienberg J, Stanyon R. Chromosome painting in mammals as an approach to comparative genomics. Curr Opin Genet Dev 1995;5:792-7.
17. Müller S, O'Brien PMC, Ferguson-Smith MA, Wienberg J. A novel source of highly specific chromosome painting probes for human karyotype analysis derived from primate homologues. Hum Genet 1997;101:149-53.
18. Müller S, Rocchi M, Ferguson-Smith MA, Wienberg J. Toward a multicolor chromosome bar code for the entire human karyotype by fluorescence in situ hybridization. Hum Genet 1997;100:271-8.
19. Müller S, O'Brien PMC, Ferguson-Smith MA, Wienberg J. Cross-species colour-segmenting: a novel tcol in human karyotype analysis. Cytometry 1998;33:445-52.
20. ISCN. An International System for Human Cytogenetics Nomenclature. Karger, Basel, 1995.
21. Espinet B, Sole F, Salido M, Lloveras E, Abella E, Besses C, et al. Application of cross-species color banding (RxFISH) in the study of T-prolymphocytic leukemia. Haematologica 2000;85:607-15.
22. Karenko L, Kahkonen M, Hyytinen ER, Lindlof M, Ranki A. Notable losses at specific regions of chromosomes 10q and 13q in Sézary syndrome detected by comparative genomic hybridization. J Invest Dermatol 1999;112:392-5.
23. Mao X, Lillington D, Scarisbrick JJ, Mitchell T, Czepulkowski B, Russell-Jones R, et al. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sėzary syndrome and mycosis fungoides. Br J Dermatol 2002;147:464-75.
24. Mao X, Lillington DM, Czepulkowski B, Russell-Jones R, Young BD, Whittaker S. Molecular cytogenetic characterization of Sézary syndrome. Genes Chromosomes Cancer 2003;36:250-60.
25. Karenko L, Sarna S, Kahkonen M, Ranki A. Chromosomal abnormalities in relation to clinical disease in patients with cutaneous T-cell lymphoma: a 5-year follow-up study. Br J Dermatol 2003;148:55-64.
26. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 2000;95:2937-42.
27. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ. Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified in 9p, 10q and 17p. J Invest Dermatol 2001;117:663-70.
28. Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker SJ. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood 2003;101:1513-9.
29. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV. Mutation of the MXI1 gene in prostate cancer. Nat Genet 1995;9:249-55.
30. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-q26.1 is deleted in malignant brain tumors. Nat Genet 1997;17:32-9.
31. Rao UN, Bakker A, Swalsky PA, Finkelstein SD. Max interacting protein 1: loss of heterozygosity is frequent in desmoplastic melanoma. Mod Pathol 1999;12:313-9.
32. GeneMap'99. Bethesda (MD): National Institutes of Health, National Center for Biotechnology Information. http://www. ncbi.nlm.nih.gov/genemap/
33. Knuutila S, Aalto Y, Autio K. Recurrent DNA sequence copy number losses and amplification in human neoplasms evaluated by comparative genomic hybridization. http://www.helsinki.fi/~gl_www/Loss+HL A/Loss_ HLA_Cover_page.html
34. Offit K, Parsa NZ, Gaidano G, Filippa DA, Louie D, Pan D, et al. 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 1993;82:2157-62.
35. Stilgenbauer S, Bullinger L, Benner A, Wildenberger K, Bentz M, Dohner K, et al. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia 1999;13:1331-4.
36. Mancini M, Vegna ML, Castoldi GL, Mecucci C, Spirito F, Elia L, et al. Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia. Leukemia 2002;16:2055-61.
37. Mitelman F, Johansson B, Mertens F, eds. Mitelman Database of Chromosome Aberrations in Cancer, 2000. http://www.cgap.nci.nih.gov/Chromosomes/Mitelman.
38. Brito-Babapulle V, Hamoudi R, Matutes E, Watson S, Kaczmarek P, Maljaie H, et al. P53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T-prolymphocytic leukaemia and Sézary syndrome. Br J Haematol 2000;110:180-7.
39. Scarisbrick JJ, Woolford AJ, Calonje E, Photiou A, Ferreira S, Orchard G, et al. Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and Sézary syndrome. J Invest Dermatol 2002;118:493-9.
40. Baur AS, Shaw P, Burri N, Delacretaz F, Bosman FT, Chaubert P. Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4b) (MTS1) in B-cell and T-cell lymphomas. Blood 1999;94:1773-81.
41. Peris K, Stanta G, Fargnoli C, Bonin S, Felli A, Amantea A, et al. Reduced expression of CDKN2a/p16 in mycosis fungoides. Arch Dermatol Res 1999;291:207-11.
42. Herman JG, Civin CI, Issa JPJ, Collector MI, Sharkis SJ, Baylin SB. Distinct patterns of inactivation of p15 (INK4B) and p16 (INK4A) characterize the major types of hematologic malignancies. Cancer Res 1997;57:837-41.
43. Teixeira MR, Micci F, Dietrich CU, Heim S. Cross-species color banding characterization of chromosomal rearrangements in leukemias with incomplete G-band karyotypes. Genes Chromosomes Cancer 1999;26:13-9.
44. Micci F, Teixeira MR, Dietrich CU, Sater G, Bjerkehagen B, Heim S. Combined RxFISH/G-banding allows refined karyotyping of solid tumors. Hum Genet 1999;104:370-5.